Menactra Vaccine 0.5 ml
1 VIAL
(Inclusive of all taxes)
Introduction of Menactra Solution for Injection
Menactra Vaccine 0.5 ml is a combination vaccine that provides protection against meningococcal disease caused by group A, C, Y, and W-135 strains of the bacteria Neisseria meningitidis and diphtheria, a serious bacterial infection that can cause a thick coating in the back of the throat, airway obstruction, and other serious complications. Menactra Vaccine is typically given to adults, adolescents, children, and infants >2 months of age, as well as to people who are at an increased risk of contracting these infections.
The Menactra Vaccine must be administered by a healthcare professional and it's crucial to complete all doses to be fully protected. Individuals are aged 15-55 who are at ongoing risk of meningococcal disease may be given a booster dose after 4-6 years. The Menactra 0.5 ml should not be given via intravenous, subcutaneous, or intradermal routes.
The Menactra Vaccine 0.5 ml may cause side effects such as injection site reactions (pain, swelling, redness), irritability, loss of appetite, drowsiness, headaches, nausea, vomiting, and diarrhoea. If these persist or worsen, inform your doctor, who may suggest ways to alleviate them.
Inform your doctor of any pre-existing conditions and medications before receiving the Menactra Vaccine 0.5 ml, as well as consulting with a doctor if you are pregnant or breastfeeding.
Uses of Menactra Solution for Injection
Prevention of Meningococcal disease: Menactra Vaccine is used in the prevention of meningococcal disease is a serious bacterial infection that affects the lining of the brain and spinal cord (meninges) and can also cause blood infections. The most common form of the disease is meningococcal meningitis, which is characterized by symptoms such as severe headache, fever, stiff neck, and a rash.
Benefits of Menactra Solution for Injection
Menactra Vaccine Reducing the risk of contracting meningococcal disease, which can be fatal if not treated promptly.
Menactra Vaccine 0.5 ml Protection against four strains of the bacteria that cause meningococcal disease (groups A, C, Y, and W-135) and also protection against diphtheria, a serious bacterial infection that affects the throat and can cause severe complications such as heart and nerve damage.
Side Effects of Menactra Solution for Injection
Like all medications, Menactra Vaccine 0.5 ml can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects of Menactra Solution for Injection
- Anorexia
- Chills
- Fever
- Vomiting
- Rash
Common Side Effects of Menactra Solution for Injection
- Injection site reactions (pain, induration, erythema, swelling),
Headache - Fatigue
- Malaise
- Arthralgia
- Diarrhoea
How to Use Menactra Solution for Injection?
Menactra Vaccine is administered by a healthcare professional or nurse in a hospital or clinic setting. The specific dosing and administration of Menactra 0.5 ml will depend on the clinical condition of the patient's age and medical history, and other factors. Kindly do not self-administer.
How Menactra Solution for Injection Works?
Menactra Vaccine 0.5 ml works by introducing a small piece of the meningococcal bacteria, called an antigen, into the body. This causes the immune system to make antibodies against the antigen, which can then recognize and attack the actual bacteria when they enter the body. This Menactra 0.5 ml contains antigens for several types of meningococcal bacteria, such as groups A, C, Y, and W-135. Diphtheria toxoid is a toxoid used in the vaccine to protect against diphtheria. Diphtheria toxoid is inactivated by treatment with formaldehyde, making it safe for use in a vaccine. The Menactra Vaccine can be used in combination with the meningococcal vaccine to protect against both diseases with a single vaccination.
Safety Advices Menactra Solution for Injection
Alcohol
UnsafeIt is generally not recommended to drink alcohol while taking Menactra Vaccine. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
Pregnancy
UnsafeUse of Menactra Vaccine may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Menactra 0.5 ml during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
Breastfeeding
UnsafeIt is not recommended to breastfeed while taking Menactra Vaccine 0.5 ml. Menactra Vaccine may pass into breast milk and harm the infant. If you are breastfeeding and taking Menactra Vaccine 0.5 ml, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
Driving
SafeIt is uncertain if the Menactra Vaccine affects one's ability to drive. If any symptoms that impair focus and reaction occur, do not operate a vehicle.
Kidney
Use with CautionMenactra 0.5 ml should be used with caution in patients with Kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Menactra Vaccine 0.5 ml and report any unusual symptoms or changes in kidney function to their doctor. The dose of Menactra Vaccine 0.5 ml may need to be adjusted in patients with kidney disease.
Liver
Use with CautionMenactra Vaccine 0.5 ml should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Menactra 0.5 ml and report any unusual symptoms or changes in liver function to their doctor. The dose of Menactra Vaccine 0.5 ml may need to be adjusted in patients with liver disease.
References
1. MENINGOCOCCAL (GROUPS A, C, Y AND W-135) POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE VACCINE, Sanofi Healthcare India Pvt. Ltd [Updated: Dec 2021], Product Leaflet
2. Menactra, Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine Solution for Intramuscular Injection, Sanofi Pasteur Inc, US FDA, Product Leaflet
3. Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Pharmacy Retailing (NZ) Ltd. [Updated 20 June 2022], Product Monograph
INDIA’S LARGEST SPECIALITY MEDICINES PLATFORM
Genuine Medicines
Fast Delivery
Secure Payment
